KA Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Kineta Bio
Kineta, Inc. is fighting to maintain its scientific potential amid acute funding shortages and intense competition. Simultaneously, the company adheres to bioethical norms and environmental production standards. The quarterly EPS growth confirms the current trend, where the metric is held at 0.00. Currently, the business's financial stability relies exclusively on external financing and grants due to a lack of recurring revenue.
Rincian metrik lan analitis perusahaan Kineta Corp (KA)
- nilai pasar lan prakiraan target analis:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Kineta, Inc.|KA - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Kineta, Inc.|KA - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Kineta Bio|KA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Kineta|Likuiditas cepet kinetabio.com
- rincian bathi lan kelipatan pasar:
KA - Bathi pungkasan|Proyeksi bathi mangsa ngarep Kineta, Inc.|KA - Pangali P/E|Rega marang bathi mangsa ngarep Kineta Bio|KA - Rasio kapitalisasi marang bathi lan wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Kineta Bio|KA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Kineta|KA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan kinetabio.com|KA - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kineta, Inc.
Pambiji fundamental perusahaan:Kineta - KA
Kineta, Inc. focuses on developing breakthrough immuno-oncology drugs for the treatment of resistant forms of cancer by targeting the VISTA pathway. The quarterly EPS growth trajectory, stripped of market noise through daily recalculation, measures the real dynamics of net income per share, allowing for an assessment of the business's financial stability and the determination of the fair value of capital amid a sideways trend.
Karo sapa Kineta, Inc. saingan
ImmunityBio (IBRX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Immunocore Holdings|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan JANX|Wutah bathi EPS kuartalan Arcus Corp|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Zymeworks Inc. (ZYME)|tangotx.com - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Iovance Biotherapeutics, Inc. IOVA|Immatics NV (IMTX) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|XNCR: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku Compass Therapeutics Corp (CMPX)|REPL (Replimune Group, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|LYEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IPHA (Innate Pharma) - Wutah bathi EPS kuartalan|PYXS: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CGEN|IOBT - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Sutro Biopharma, Inc. STRO|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan INKT|Werewolf - Wutah bathi EPS kuartalan|IMMX - Wutah bathi EPS kuartalan|ALX Oncology (ALXO) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan CUE (Cue Biopharma Inc.)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan PDSB|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Sonnet BioTherapeutics Holdings Inc. SONN|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MAIA Biotechnology, Inc. (MAIA)|Wutah bathi EPS kuartalan Liminatus Pharma Inc. (LIMN)|Wutah bathi EPS kuartalan LVTX (LAVA Therapeutics)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan NextCure Corporation (NXTC)|LPTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|INTS (Intensity Therapeutics) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|SNSE: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Theriva Biologics Inc (TOVX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan GRTS|NEXI (NexImmune Corporation) - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan TSBX|Wutah bathi EPS kuartalan vaccinex.com (VCNX)|Harpoon Therapeutics, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan
